Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer

Annals of Surgery

Volumn 260, Issue 6, 2014, Pages 1073-1080

  Jain, Kajal ^a   Mohapatra, Trilochan ^b   Das, Prasenjit ^a   Misra, Mahesh Chandra ^a   Gupta, Siddhartha Datta ^b   Ghosh, Manju ^a   Kabra, Madhulika ^a   Bansal, Virinder Kumar ^a   Kumar, Subodh ^a   Sreenivas, Vishnubhatla ^a   Garg, Pramod Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN AGRICULTURAL RESEARCH INSTITUTE   (India)

Author keywords

Dysplasia; Gallbladder cancer; Gallstones; Loss of heterozygosity

Indexed keywords

APC PROTEIN; DUTT1 PROTEIN; FCMD PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P16; PROTEIN P27; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA;

ADULT; AGED; APC GENE; ARTICLE; CARCINOMA IN SITU; CAUSAL ATTRIBUTION; CHOLECYSTECTOMY; CHOLELITHIASIS; CROSS-SECTIONAL STUDY; DCC GENE; DISEASE ASSOCIATION; DUTT1 GENE; DYSPLASIA; FCMD GENE; FEMALE; FHIT GENE; GALLBLADDER CANCER; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; METAPLASIA; MICROSATELLITE MARKER; P16 GENE; P53 GENE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RB1 GENE; TUMOR SUPPRESSOR GENE; ADOLESCENT; COMPLICATION; FOLLOW UP; GALLBLADDER NEOPLASMS; GALLSTONE; GENETICS; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DNA; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; GALLSTONES; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84922271286     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000495     Document Type: Article

References (32)

1. Batra Y, Pal S, Dutta U, et al. Gallbladder cancer in India: A dismal picture. J Gastroenterol Hepatol. 2005;20: 309-314.
2. Wistuba II, Gazdar AF. Gallbladder cancer: Lessons from a rare tumour. Nat Rev. 2004;4: 695-706.
3. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer. 2006;118: 1592-1602.
4. Raina V, Tyagi BB, Manoharan N, et al. Cancer Incidence & Mortality in Delhi UT Urban, 2006. Delhi Cancer Registry; 2010.
5. Dutta U, Garg PK, Kumar R, et al. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol. 2000;95: 784-787.
6. Jain K, Sreenivas V, Velpandian T, et al. Risk factors for gallbladder cancer: A case-control study. Int J Cancer. 2013;132: 1660-1666.
7. Graham EA. The prevention of carcinoma of the gallbladder. Ann Surg. 1931;93: 317-322.
8. Roa I, Aretxabala X, Araya JC, et al. Preneoplastic lesions in gallbladder cancer. J Surg Oncol. 2006;93: 615-623.
9. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-Tumor development. N Eng J Med. 1988;319: 525-532.
10. Duarte I, Llanos O, Domke H, et al. Metaplasia and precursor lesions of gallbladder carcinoma. Cancer. 1993;72: 1878-1884.
11. Albores-Saavedra J, Alcantara-Vazquez A, Cruz-Oritz H, et al. The precursor lesions of invasive gallbladder carcinoma: Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer. 1980;45: 919-927.
12. Kuroki T, Tajima Y, Matsou K, et al. Genetic alterations in Gallbladder carcinoma. Surg Today. 2005;35: 101-105.
13. Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60: 1949-1960.
14. Boldog F, Gemmill RM, West J, et al. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet. 1997;6: 193-203.
15. Wistuba I, Behrens C, Milchgrub S, et al. Comparison of molecular changes in Lung cancers in HIV-positive and HIV-Indeterminate subjects. JAMA. 1998;279: 1554-1560.
16. Toh Y, Oki E, Oda S, et al. An integrated microsatellite length analysis using automated fluorescent DNA sequencer. Cancer Res. 1996;56: 2688-2691.
17. Wang Y, Hung S, Linn JF, et al. Microsatellite-based cancer detection using capillary array electrophoresis and energy-Transfer fluorescent primers. Electrophoresis. 1997;18: 1742-1749.
18. Dietmaier W, Riedlinger W, Kohler A, et al. Detection of microsatellite instability (MSI) and loss of heterozygosity (LOH) in colorectal tumors by fluorescence-based multiplex microsatellite PCR. Biochemica. 1999;2: 42-45.
19. Maitra A, Wistuba II, Washington C, et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allelic loss. Am J Pathol. 2001;159: 119-130.
20. Leitch A. Gallstones and cancer of the gallbladder: An experimental study. BMJ. 1924;2: 451-454.
21. Mukhopadhyay -Landas. Putative precursors of gallbladder dysplasia: A review of 400 routinely resected specimens. Arch Pathol LabMed. 2004;129: 386-390.
22. Gupta SC, Misra V, Singh PA, et al. Gallstones and carcinoma gallbladder. Indian J Pathol Microbiol. 2000;43: 147-154.
23. Dowling GP, Kelly JK. The histogenesis of adenocarcinoma of the gallbladder. Cancer. 1986;58: 1702-1708.
24. Saetta AA. K-ras, p53 mutations and microsatellite instability (MSI) in gallbladder cancer. J Surg Oncol. 2006;93: 644-649.
25. Wistuba II, Tang M, Maitra A, et al. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res. 2001;61: 3795-3800.
26. Wistuba II, Maitra A, Carrasco R, et al. High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer. 2002;87: 432-440.
27. Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: Interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31: 37-49.
28. Shem EB, Fintsi Y, Avinoach I, et al. p53 expression in tissue adjacent to endometrial carcinoma. Eur J Gynaecol Oncol. 2002;23: 548-550.
29. Ye B, Wang X, Yang Z, et al. p53 and p73 expression in esophageal carcinoma correlate with clinicopathology of tumors. Hepatogastroenterology. 2012;59: 2192-2195.
30. PadmaPriya T, Kapoor VK, Krishnani N, et al. Role of E-cadherin gene in gallbladder cancer and its precursor lesions. Virchows Arch. 2010;456: 507-514.
31. Puhalla H, Kandioler D, Ludwig C, et al. p53 analysis in gallbladder cancer: Comparison of gene analysis versus immunohistochemistry. Anticancer Res. 2004;24: 1201-1206.
32. Tadokoro H, Shigihara T, Ikeda T, et al. Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol. 2007;13: 6396-6403.